• Tue, January 28, 2014
  • Wed, January 29, 2014
  • Fri, January 31, 2014
  • Thu, January 30, 2014

Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $50 on, Jan 28th, 2014

Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $47 to $50 on, Jan 28th, 2014.

Liav has made no other calls on TEVA in the last 4 months.



There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Liav's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


This is the rating of the analyst that currently disagrees with Liav


  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $38 on, Monday, November 4th, 2013